EORTC QLQ-C30、QLQ-CR38 和 FACT-C 生活质量问卷在结直肠癌患者中的反应性。
Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer.
机构信息
Centre Alexis Vautrin, Department of Medical Oncology, Nancy, France.
出版信息
Health Qual Life Outcomes. 2011 Aug 22;9:70. doi: 10.1186/1477-7525-9-70.
Abstract
BACKGROUND
The aim of this study was to compare the responsiveness of the European Organization for Research and Treatment (EORTC) quality of life questionnaires (QLQ-C30, QLQ-CR38) and the Functional Assessment of Cancer Therapy-colorectal version 4 questionnaire (FACT-C).
METHOD
This prospective study included 127 patients with colorectal cancer: 71 undergoing chemotherapy and 56 radiation therapy. Responsiveness statistics included the Standardized Response Mean (SRM) and the Effect Size (ES). The patient's overall assessment of his/her change in state of health status was the reference criterion to evaluate the responsiveness of the QoL questionnaires.
RESULTS
34 patients perceived their health as stable and 17 as improved between the first and the fourth courses of chemotherapy. 21 patients perceived their health as stable and 22 as improved between before and the last week of radiotherapy.The responsiveness of the 3 questionnaires differed according to treatments. The EORTC QLQ-C30 questionnaire was more responsive in patients receiving chemotherapy, particulary functional scales (SRM > 0.55). The QLQ-CR38 and the FACT-C questionnaires provided little clinically relevant information during chemotherapy or radiotherapy.
CONCLUSION
The EORTC QLQ-C30 questionnaire appears to be more responsive in patients receiving chemotherapy.
摘要
背景
本研究旨在比较欧洲癌症研究与治疗组织（EORTC）生活质量问卷（QLQ-C30、QLQ-CR38）和癌症治疗功能评估-结肠直肠版 4 问卷（FACT-C）的反应性。
方法
本前瞻性研究纳入了 127 例结直肠癌患者：71 例接受化疗，56 例接受放疗。反应性统计包括标准化反应均值（SRM）和效应量（ES）。患者对其健康状况变化的整体评估是评估生活质量问卷反应性的参考标准。
结果
34 例患者认为他们的健康状况在第一至第四疗程化疗期间保持稳定，17 例患者认为他们的健康状况有所改善。21 例患者认为他们的健康状况在放疗前和最后一周保持稳定，22 例患者认为他们的健康状况有所改善。3 种问卷的反应性因治疗而异。EORTC QLQ-C30 问卷在接受化疗的患者中更具反应性，特别是功能量表（SRM > 0.55）。QLQ-CR38 和 FACT-C 问卷在化疗或放疗期间提供的临床相关信息较少。
结论
EORTC QLQ-C30 问卷在接受化疗的患者中似乎更具反应性。
相似文献
1
Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer.EORTC QLQ-C30、QLQ-CR38 和 FACT-C 生活质量问卷在结直肠癌患者中的反应性。
Health Qual Life Outcomes. 2011 Aug 22;9:70. doi: 10.1186/1477-7525-9-70.
2
Validation of the French version of the colorectal-specific quality-of-life questionnaires EORTC QLQ-CR38 and FACT-C.欧洲癌症研究与治疗组织结直肠癌特异性生活质量问卷（EORTC QLQ-CR38）和癌症治疗功能评估结直肠癌问卷（FACT-C）法语版本的验证
Qual Life Res. 2008 Apr;17(3):437-45. doi: 10.1007/s11136-008-9322-9. Epub 2008 Mar 13.
3
Comparison of the FACT-C, EORTC QLQ-CR38, and QLQ-CR29 quality of life questionnaires for patients with colorectal cancer: a literature review.用于结直肠癌患者的FACT-C、欧洲癌症研究与治疗组织核心生活质量问卷CR38和核心生活质量问卷CR29生活质量问卷比较：一项文献综述
Support Care Cancer. 2016 Aug;24(8):3661-8. doi: 10.1007/s00520-016-3270-7. Epub 2016 May 18.
4
The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.欧洲癌症研究与治疗组织结直肠癌特异性生活质量问卷模块（QLQ-CR38）的构建与测试。欧洲癌症研究与治疗组织生活质量研究小组
Eur J Cancer. 1999 Feb;35(2):238-47. doi: 10.1016/s0959-8049(98)00357-8.
5
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.微卫星不稳定高或错配修复缺陷转移性结直肠癌患者一线帕博利珠单抗与化疗治疗的健康相关生活质量（KEYNOTE-177）：一项开放标签、随机、III 期试验。
Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1.
6
Psychometric validation of the Moroccan version of the EORTC QLQ-C30 in colorectal Cancer patients: cross-sectional study and systematic literature review.《EORTC QLQ-C30 量表在摩洛哥结直肠癌患者中的信度和效度验证：横断面研究和系统文献回顾》。
BMC Cancer. 2021 Jan 27;21(1):99. doi: 10.1186/s12885-021-07793-w.
7
Assessment of change of quality of life in terminally ill patients under cancer pain management using the EORTC Core Quality of Life Questionnaire (QLQ-C30) in a Korean sample.使用欧洲癌症研究与治疗组织核心生活质量问卷（QLQ-C30）对韩国样本中接受癌症疼痛管理的晚期患者的生活质量变化进行评估。
Oncology. 2008;74 Suppl 1:7-12. doi: 10.1159/000143212. Epub 2008 Aug 28.
8
Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.验证丹麦版 EORTC QLQ-CR38 疾病特异性量表用于评估结直肠癌患者的健康相关生活质量。
Health Qual Life Outcomes. 2012 Dec 14;10:150. doi: 10.1186/1477-7525-10-150.
9
Psychometric analysis of the Korean version of the high-dose chemotherapy specific quality of life questionnaire module from the European Organization for Research and Treatment of Cancer (EORTC QLQ-HDC29).欧洲癌症研究与治疗组织（EORTC QLQ-HDC29）高剂量化疗特异性生活质量问卷模块韩文版的心理测量分析。
Qual Life Res. 2016 Apr;25(4):881-90. doi: 10.1007/s11136-015-1121-5. Epub 2015 Sep 5.
10
Predicting SF-6D from the European Organization for Treatment and Research of Cancer Quality of Life Questionnaire scores in patients with colorectal cancer.预测结直肠癌患者欧洲癌症研究与治疗组织生活质量问卷评分的 SF-6D 得分。
Value Health. 2013 Mar-Apr;16(2):373-84. doi: 10.1016/j.jval.2012.12.004.
引用本文的文献
1
Defining and Assessing Distress in Oncology Patients: A Systematic Review of the Literature.定义和评估肿瘤患者的痛苦：文献系统综述
Healthcare (Basel). 2025 Aug 12;13(16):1976. doi: 10.3390/healthcare13161976.
2
Prospective longitudinal trajectory of cancer survivorship among patients with recurrent rectal cancer: impact of treatment modalities and resection status.复发性直肠癌患者癌症幸存者的前瞻性纵向轨迹：治疗方式和切除状态的影响
Colorectal Dis. 2025 May;27(5):e70110. doi: 10.1111/codi.70110.
3
Internal Responsiveness of EQ-5D-5L and EORTC QLQ-C30 in Dutch Breast Cancer Patients during the First Year Post-Surgery: A Longitudinal Cohort Study.荷兰乳腺癌患者术后第一年EQ-5D-5L和EORTC QLQ-C30的内部反应性：一项纵向队列研究。
Cancers (Basel). 2024 May 21;16(11):1952. doi: 10.3390/cancers16111952.
4
Impact of Systemic Treatments on Outcomes and Quality of Life in Patients with RAS-Positive Stage IV Colorectal Cancer: A Systematic Review.全身治疗对RAS阳性IV期结直肠癌患者预后及生活质量的影响：一项系统评价
Diseases. 2024 Apr 20;12(4):79. doi: 10.3390/diseases12040079.
5
Relationship of Hepatocellular Carcinoma Stage and Hepatic Function to Health-Related Quality of Life: A Single Center Analysis.肝细胞癌分期及肝功能与健康相关生活质量的关系：单中心分析
Healthcare (Basel). 2023 Sep 18;11(18):2571. doi: 10.3390/healthcare11182571.
6
Quality of Life in Cancer Patients: The Modern Psycho-Oncologic Approach for Romania-A Review.癌症患者的生活质量：罗马尼亚的现代精神肿瘤学方法-综述。
Curr Oncol. 2023 Jul 20;30(7):6964-6975. doi: 10.3390/curroncol30070504.
7
Study protocol of an open-label, single arm phase II trial investigating the efficacy and safety of Trifluridine/Tipiracil combined with irinotecan as a second line therapy in patients with cholangiocarcinoma (TRITICC).一项开放标签、单臂 II 期临床试验的研究方案，旨在研究替氟尿苷/替匹嘧啶联合伊立替康作为二线治疗胆管癌患者的疗效和安全性（TRITICC）。
BMC Cancer. 2023 May 22;23(1):470. doi: 10.1186/s12885-023-10972-6.
8
Evaluating the Safety and Quality of Life of Colorectal Cancer Patients Treated by Autologous Immune Enhancement Therapy (AIET) in Vinmec International Hospitals.评价自体免疫增强疗法（AIET）治疗的结直肠癌患者的安全性和生活质量。
Int J Mol Sci. 2022 Sep 26;23(19):11362. doi: 10.3390/ijms231911362.
9
Can baseline quality of life scores predict for morbidity and survival after CRS and HIPEC: a prospective study of 151 patients.基线生活质量评分能否预测结直肠癌根治术及腹腔热灌注化疗后的发病率和生存率：一项对151例患者的前瞻性研究。
Pleura Peritoneum. 2022 Apr 4;7(2):63-75. doi: 10.1515/pp-2021-0148. eCollection 2022 Jun 1.
10
Quality of life in Tunisian colorectal cancer patients: a cross-sectional study.突尼斯结直肠癌患者的生活质量：一项横断面研究。
J Cancer Res Clin Oncol. 2023 Jul;149(7):2735-2742. doi: 10.1007/s00432-022-04154-3. Epub 2022 Jun 30.
本文引用的文献
1
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.EORTC QLQ-CR29 问卷模块评估结直肠癌患者健康相关生活质量的临床和心理计量学验证。
Eur J Cancer. 2009 Nov;45(17):3017-26. doi: 10.1016/j.ejca.2009.08.014. Epub 2009 Sep 16.
2
Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice.探索临床研究中与健康相关的生活质量信息的价值并将其应用于临床实践。
Mayo Clin Proc. 2007 Oct;82(10):1229-39. doi: 10.4065/82.10.1229.
3
Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire.评估结直肠癌患者的生活质量：欧洲癌症研究与治疗组织生活质量问卷的更新
Eur J Cancer. 2007 Jul;43(10):1564-73. doi: 10.1016/j.ejca.2007.04.005. Epub 2007 May 22.
4
Minimally important differences were estimated for the Functional Assessment of Cancer Therapy-Colorectal (FACT-C) instrument using a combination of distribution- and anchor-based approaches.采用基于分布和锚定的方法相结合，对癌症治疗功能评估-结直肠癌（FACT-C）工具的最小重要差异进行了估计。
J Clin Epidemiol. 2005 Dec;58(12):1241-51. doi: 10.1016/j.jclinepi.2005.07.008. Epub 2005 Oct 13.
5
Methods to detect response shift in quality of life data: a convergent validity study.生活质量数据中反应转移的检测方法：一项收敛效度研究。
Qual Life Res. 2005 Apr;14(3):629-39. doi: 10.1007/s11136-004-2577-x.
6
French version of FACT-G: validation and comparison with other cancer-specific instruments.FACT-G的法语版本：验证及与其他癌症专用工具的比较。
Eur J Cancer. 2004 Oct;40(15):2243-52. doi: 10.1016/j.ejca.2004.06.010.
7
Health-related quality of life in colorectal cancer patients.
Expert Rev Anticancer Ther. 2003 Aug;3(4):493-504. doi: 10.1586/14737140.3.4.493.
8
On assessing responsiveness of health-related quality of life instruments: guidelines for instrument evaluation.关于评估健康相关生活质量工具的反应性：工具评估指南
Qual Life Res. 2003 Jun;12(4):349-62. doi: 10.1023/a:1023499322593.
9
Quality of life during radiotherapy for rectal cancer.
Eur J Cancer. 2003 Mar;39(5):587-94. doi: 10.1016/s0959-8049(02)00741-4.
10
Quality of life measurement: bibliographic study of patient assessed health outcome measures.生活质量测量：患者评估的健康结局测量的文献研究
BMJ. 2002 Jun 15;324(7351):1417. doi: 10.1136/bmj.324.7351.1417.
Zotero 插件